Rankings / Metabolic Health

Ezetimibe

Metabolic Health · NPC1L1 inhibitor

Also known as: Zetia

Tier A+

Reviewed by Read Off Label · Last reviewed · How we grade

prescription
8.4 / 10
Tier A+
Ev 8 Bn 5 Sf 10

Bottom line

Read Off Label grades Ezetimibe as A+ (8.4/10) based on strong evidence, moderate benefit magnitude, and a very low-risk safety profile.

Ezetimibe is generic and inexpensive.

Studied, labeled, or reported-use context: 10 mg PO daily — Rx; not individualized guidance.

Citation correction in progress

1 PubMed link was found to be unrelated to this entry and removed from public output. The remaining sources are shown below, but this row's claims and score still need a full source-by-source revalidation.

What the evidence says

Ezetimibe is generic and inexpensive. Clinical guidelines commonly position it as an add-on when statin therapy is insufficient or not tolerated; trials and labeling report a low adverse-effect burden. IMPROVE-IT 2015 established CV benefit of ezetimibe-on-statin in post-ACS. SaveSAMS subgroup (JAHA 2026, n=318, ASCVD patients aged >=70) found moderate-intensity statin + ezetimibe matched high-intensity statin monotherapy on LDL-C target attainment while causing fewer muscle symptoms (0.7% vs 5.4%) and less lipoprotein(a) rise -- reported fewer muscle symptoms than high-intensity statin monotherapy in the studied older ASCVD subgroup.

Mechanism

Inhibits Niemann-Pick C1-like 1 transporter at intestinal brush border; reduces dietary and biliary cholesterol absorption; ~15-20% LDL reduction as monotherapy; synergistic with statins

Studied, labeled, or reported dose & route

10 mg PO daily

This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.

Citations

A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.

Common questions

What does the evidence show about Ezetimibe's effects?
Read Off Label rates the evidence for Ezetimibe as Strong and the benefit magnitude as moderate, producing an overall grade of A+ (8.4/10). Ezetimibe is generic and inexpensive.
What safety findings are reported for Ezetimibe?
Ezetimibe has a very low risk profile in the database. Very Low (few adverse effects reported in trials and labeling) Legal status: Rx (generic).
What doses or routes are reported for Ezetimibe?
10 mg PO daily This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
How does Ezetimibe work?
Inhibits Niemann-Pick C1-like 1 transporter at intestinal brush border; reduces dietary and biliary cholesterol absorption; ~15-20% LDL reduction as monotherapy; synergistic with statins

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.